Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a publicly traded Healthcare sector company. As of October 29, 2026, SGMT trades at $10.80 with a market cap of $738.87M and a P/E ratio of -5.63. SGMT moved +0.00% today. Year to date, SGMT is +79.30%; over the trailing twelve months it is +30.34%. Its 52-week range spans $1.73 to $11.45. Analyst consensus is strong buy with an average price target of $28.46. Rallies surfaces SGMT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks SGMT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $10.80 |
| Market Cap | $738.87M |
| P/E Ratio | -5.63 |
| EPS | $-1.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.45 |
| 52-Week Low | $1.73 |
| Volume | 30.31K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-51.04M |
| Gross Margin | 0.00% |
12 analysts cover SGMT: 0 strong buy, 11 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $28.46.